Skip to main content
SpringerLink
Log in

Antibodies against C1q in patients with systemic lupus erythematosus

  • Original Article
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Abstract

The first component of the classical pathway of complement (C1q) is considered to be involved in the pathogenesis of systemic lupus erythematosus (SLE). This view is based on the observation that a substantial number of patients with SLE develop hypocomplementemia with depletion of the classical pathway components, and C1q has been shown to play an important role in the clearance of immune complexes and apoptotic bodies. In addition, homozygous C1q deficiency is the strongest disease susceptibility gene for the development of SLE that has been characterised in humans. However, most SLE patients have no primary complement deficiency. Hypocomplementemia in SLE patients is a secondary event and often associated with antibodies against C1q (anti-C1q). Although anti-C1q have been found in a number of distinct autoimmune disorders, they are best described in patients with SLE where they strongly correlate with renal flares. Current data suggest that the occurrence of anti-C1q in SLE patients is necessary but not sufficient for the development of proliferative lupus nephritis, suggesting an interference with the normal function of the complement system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Agnello V, Koffler D, Eisenberg JW, Winchester RJ, Kunkel HG (1971) C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 134(Suppl):228–241

    Google Scholar 

  2. Antes U, Heinz HP, Loos M (1988) Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus. Arthritis Rheum 31:457–464

    Article  PubMed  CAS  Google Scholar 

  3. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55–60

    Article  PubMed  CAS  Google Scholar 

  4. Berner B, Scheel AK, Schettler V, Hummel KM, Reuss-Borst MA, Muller GA, Oestmann E, Leinenbach HP, Hepper M (2001) Rapid improvement of SLE-specific cutaneous lesions by C1q immunoadsorption. Ann Rheum Dis 60:898–899

    PubMed  CAS  Google Scholar 

  5. Botto M, Walport MJ (2002) C1q, autoimmunity and apoptosis. Immunobiology 205:395–406

    Article  PubMed  CAS  Google Scholar 

  6. Botto M, Dell'Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59

    Article  PubMed  CAS  Google Scholar 

  7. Cacoub P, Fremeaux-Bacchi V, De Lacroix I, Guillien F, Kahn MF, Kazatchkine MD, Godeau P, Piette JC (2001) A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum 44:1836–1840

    Article  PubMed  CAS  Google Scholar 

  8. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330

    Article  PubMed  CAS  Google Scholar 

  9. Coremans IE, Spronk PE, Bootsma H, Daha MR, van der Voort EA, Kater L, Breedveld FC, Kallenberg CG (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26:595–601

    PubMed  CAS  Google Scholar 

  10. Fremeaux-Bacchi V, Noel LH, Schifferli JA (2002) No lupus nephritis in the absence of anti-C1q autoantibodies? Nephrol Dial Transplant 17:2041–2043

    Article  PubMed  CAS  Google Scholar 

  11. Fremeaux-Bacchi V, Weiss L, Demouchy C, Blouin J, Kazatchkine MD (1996) Autoantibodies to the collagen-like region of C1q are strongly associated with classical pathway-mediated hypocomplementemia in systemic lupus erythematosus. Lupus 5:216–220

    Article  PubMed  CAS  Google Scholar 

  12. Gaboriaud C, Thielens NM, Gregory LA, Rossi V, Fontecilla-Camps JC, Arlaud GJ (2004) Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol 25:368–373

    Article  PubMed  CAS  Google Scholar 

  13. Gaipl US, Kuenkele S, Beyer TD, Kolowos W, Heyder P, Kalden JR, Hermann M (2001) Complement binding is an early feature of necrotic and a rather late event during apoptotic cell death. Cell Death Differ 8:327–334

    Article  PubMed  CAS  Google Scholar 

  14. Golan MD, Burger R, Loos M (1982) Conformational changes in C1q after binding of immune complexes: detection of neoantigens with monoclonal antibodies. J Immunol 129:445–447

    PubMed  CAS  Google Scholar 

  15. Grimbert P, Schulte K, Buisson C, Desvaux D, Baron C, Pastural M, Dhamane D, Remy P, Weil B, Lang P (2001) Renal transplantation in a patient with hypocomplementemic urticarial vasculitis syndrome. Am J Kidney Dis 37:144–148

    PubMed  CAS  Google Scholar 

  16. Gunnarsson I, Sundelin B, Heimburger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH (2002) Repeated renal biopsy in proliferative lupus nephritis–predictive role of serum C1q and albuminuria. J Rheumatol 29:693–699

    PubMed  Google Scholar 

  17. Gunnarson I, Ronnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L (1997) Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 36:32–37

    Article  PubMed  Google Scholar 

  18. Gunnarson I, Ronnelid J, Lundberg I, Jacobson H (1997) Occurrence of anti-C1q antibodies in IgA nephropathy. Nephrol Dial Transplant 12:2263–2268

    Article  PubMed  Google Scholar 

  19. Haseley LA, Wisnieski JJ, Denburg MR, Michael-Grossman AR, Ginzler EM, Gourley MF, Hoffman JH, Kimberly RP, Salmon JE (1997) Antibodies to C1q in systemic lupus erythematosus: chracteristics and relation to FcRIIA alleles. Kidney Int 52:1375–1380

    Article  PubMed  CAS  Google Scholar 

  20. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR (1998) Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41:1241–1250

    Article  PubMed  CAS  Google Scholar 

  21. Horvath L, Czirjak L, Fekele B, Jakab L, Pozsonyi T, Kalabay L, Romics L, Miklos K, Varga L, Prohaszka Z, Szakacs A, Nagy E, Daha MR, Fust G (2001) High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 19:667–672

    PubMed  CAS  Google Scholar 

  22. Kohro-Kawata J, Wener MH, Mannik M (2002) The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus. J Rheumatol 29:84–89

    PubMed  CAS  Google Scholar 

  23. Korb LC, Ahearn JM (1997) C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J Immunol 158:4525–4528

    PubMed  CAS  Google Scholar 

  24. Kozyro I, Perahud I, Sadallah S, Sukalo AV, Titov LP, Schifferli JA, Trendelenburg M (2004) Clinical value of autoantibodies against C1q in children with glomerulonephritis. Kidney Blood Press Res 27:392

    Google Scholar 

  25. Mannik M, Wener M (1997) Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum 40:1504–1511

    Article  PubMed  CAS  Google Scholar 

  26. Martensson U, Sjoholm AG, Sturfelt G, Truedsson L, Laurell AB (1992) Western blot analysis of human IgG reactive with the collageneous portion of C1q: evidence of distinct binding specificities. Scand J Immunol 35:735–744

    Article  PubMed  CAS  Google Scholar 

  27. Martensson U, Thiel S, Jensenius JC, Sjoholm AG (1996) Human autoantibodies against C1q: lack of cross-reactivity with the collectins mannan-binding protein, lung surfactant protein A and bovine conglutinin. Scand J Immunol 43:314–320

    PubMed  CAS  Google Scholar 

  28. Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA (2004) Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis 64(3):444–448. DOI 10.1136/ard.2004.024943

    Article  PubMed  CAS  Google Scholar 

  29. Mevorach D, Zhou JL, Song X, Elkon KB (1998) Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med 188:387–392

    Article  PubMed  CAS  Google Scholar 

  30. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313–2320

    Article  PubMed  CAS  Google Scholar 

  31. Moroni G, Trendelenburg M, Del Papa N, Quaglini S, Raschi E, Panzeri P, Testoni C, Tincani A, Banfi G, Balestrieri G, Schifferli JA, Meroni PL, Ponticelli C (2001) Anti-C1q antibodies may help in diagnosing renal flare in lupus nephritis. Am J Kidney Dis 37:490–498

    PubMed  CAS  Google Scholar 

  32. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166:3231–3239

    PubMed  CAS  Google Scholar 

  33. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic bodies. J Exp Med 194:781–796

    Article  PubMed  CAS  Google Scholar 

  34. Pfueller B, Wolbart K, Bruns A, Burmester GR, Hiepe F (2001) Successful treatment of patients with SLE by immunoadsorption with a C1q column: a pilot study. Arthritis Rheum 44:1962–1963

    Article  PubMed  CAS  Google Scholar 

  35. Pickering MC, Botto M, Taylor PR, Lachmann PJ, Walport MJ (2000) Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 76:227–334

    PubMed  CAS  Google Scholar 

  36. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ (2003) Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 170:3223–3232

    PubMed  CAS  Google Scholar 

  37. Prada AE, Strife CF (1992) IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis. Clin Immunol Immunopathol 63:84–88

    Article  PubMed  CAS  Google Scholar 

  38. Prohaszka Z, Daha MR, Susal C, Daniel V, Szlavik J, Banhegyi D, Nagy K, Varkonyi V, Horvath A, Ujhelyi E, Toth FD, Uray K, Hudecz F, Fust G (1999) C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin Immunol 90:247–255

    Article  PubMed  CAS  Google Scholar 

  39. Ravelli A, Wisnieski JJ, Ramenghi B, Ballardini G, Zonta L, Martini A (1997) IgG autoantibodies to complement C1q in pediatric-onset systemic lupus erythematosus. Clin Exp Rheumatol 15:215–219

    PubMed  CAS  Google Scholar 

  40. Ronnelid J, Huang YH, Norrlander T, Rogberg S, Nilsson B, Gustafsson R, Klareskog L (1994) Short-term kinetics of the humoral anti-C1q response in SLE using ELISPOT method: fast decline in production in response to steroids. Scand J Immunol 40:243–250

    Article  PubMed  CAS  Google Scholar 

  41. Siegert CE, Daha MR, van der Voort EAM, Breedveld FC (1990) IgG and IgA antibodies to the collagen-like region of C1q in rheumatoid vasculitis. Arthritis Rheum 33:1464–1654

    Article  Google Scholar 

  42. Siegert CE, Daha MR, Halma C, van der Voort EA, Breedveld FC (1992) IgG and IgA autoantibodies to C1q in systemic and renal diseases. Clin Exp Rheumatol 10:19–23

    PubMed  CAS  Google Scholar 

  43. Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F (1991) IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18:230–234

    PubMed  CAS  Google Scholar 

  44. Siegert CEH, Daha MR, Swaak AJG, van der Voort EAM, Breedveld FC (1993) The relationship between serum titres of autoantibodies against C1q and age in the general population and in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 67:204–209

    Article  PubMed  CAS  Google Scholar 

  45. Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC (1993) Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:851–856

    PubMed  CAS  Google Scholar 

  46. Siegert CE, Kazatchkine MD, Sjoholm A, Wurzner R, Loos M, Daha MR (1999) Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol 116:4–8

    Article  PubMed  CAS  Google Scholar 

  47. Siegert CE, Daha MR, Lobatto S, van der Voort EA, Breedveld FC (1992) IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus. Immunol Res 11:91–97

    PubMed  CAS  Google Scholar 

  48. Sjoholm AG, Martensson U, Sturfelt G (1997) Serial analysis of autoantibody responses to the collagen-like region of C1q, collagen type II, and double-stranded DNA in patients with systemic lupus erythematosus. J Rheumatol 24:871–878

    PubMed  CAS  Google Scholar 

  49. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC, Savill JS, Henson PM, Botto M, Walport MJ (2000) A hierarchical role for classical pathway complement proteins in the clearance of apoptotic bodies in vivo. J Exp Med 192:359–366

    Article  PubMed  CAS  Google Scholar 

  50. Trendelenburg M, Courvoisier S, Spaeth PJ, Moll S, Mihatsch M, Itin P, Schifferli JA (1999) Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Am J Kidney Dis 34:745–751

    PubMed  CAS  Google Scholar 

  51. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA (1999) Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody negative patients. Arthritis Rheum 42:187–188

    Article  PubMed  CAS  Google Scholar 

  52. Trendelenburg M, Schifferli JA (1998) Is autoantibody determination in patients with systemic lupus erythematosus useful? Anti-C1q-autoantibody as an example. Schweiz Rundsch Med Prax 87:1811–1813

    PubMed  CAS  Google Scholar 

  53. Trouw LA, Seelen MA, Duijs JMGJ, Benediktsson H, Van Kooten C, Daha MR (2003) Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of anti-mouse C1q antibodies. Clin Exp Immunol 132:32–39

    Article  PubMed  CAS  Google Scholar 

  54. Trouw LA, Groeneveld TWL, Seelen MA, Dujis JMGJ, Bajema IM, Prins FA, Kishore U, Salant DJ, Verbeek JS, Van Kooten C, Daha MR (2004) Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes. J Clin Invest 114:679–688

    Article  PubMed  CAS  Google Scholar 

  55. Uwatoko S, Aotsuka S, Okawa M, Egusa Y, Yokohari R, Aizawa C, Suzuki K (1984) Characterisation of C1q-binding IgG complexes in systemic lupus erythematosus. Clin Immunol Immunopathol 30:104–116

    Article  PubMed  CAS  Google Scholar 

  56. Uwatoko S, Mannik M (1988) Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest 82:816–824

    Article  PubMed  CAS  Google Scholar 

  57. Uwatoko S, Gauthier VJ, Mannik M (1991) Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol 61:268–273

    Article  PubMed  CAS  Google Scholar 

  58. Wener MH, Mannik M, Schwartz MM, Lewis EJ (1987) Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) 66:85–97

    CAS  Google Scholar 

  59. Wener MH, Uwatoko S, Mannik M (1989) Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum 32:544–551

    Article  PubMed  CAS  Google Scholar 

  60. Wisnieski JJ, Baer AN, Christensen J, Cupps TR, Flagg DN, Jones JV, Katzenstein PL, McFadden ER, McMillen JJ, Pick MA (1995) Hypocomplementemic urticarial vasculitis syndrome. Clinical and serological findings in 18 patients. Medicine (Baltimore) 74:24–41

    Article  CAS  Google Scholar 

  61. Wisnieski JJ, Jones SM (1992) IgG autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus and six other skeletal or rheumatic diseases. J Rheumatol 19:884–888

    PubMed  CAS  Google Scholar 

  62. Wisnieski JJ, Jones SM (1992) Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 148:1396–1403

    PubMed  CAS  Google Scholar 

  63. Yee CS, Hussein H, Skan J, Bowman S, Situnayake D, Gordon C (2003) Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology 42:276–279

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Clinic B, University Hospital Basel, Petersgraben 4, Basel, 4031, Switzerland

    Marten Trendelenburg

Authors
  1. Marten Trendelenburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marten Trendelenburg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trendelenburg, M. Antibodies against C1q in patients with systemic lupus erythematosus. Springer Semin Immun 27, 276–285 (2005). https://doi.org/10.1007/s00281-005-0007-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00281-005-0007-y

Keywords

Search

Navigation